One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Smarter, safer, and more reliable—this new model could reshape the way AI evolves.

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...

Google's DeepMind launches AlphaGenome, an artificial intelligence model that predicts gene expression from DNA sequence.

An artificial intelligence (AI) model developed by Google DeepMind in London could help scientists to make sense of this ...

Demonstrators gathered outside Google DeepMind's London office on Monday to accuse the company of reneging on a key AI ...

Google DeepMind is rolling out an on-device version of its Gemini Robotics AI model that allows it to operate without an ...

DeepMind has been exploring the potential risks of AI since before ChatGPT appeared, and Shane Legg, one of the company’s cofounders, has led an “AI safety” group within the company for years.

DeepMind ran at a loss for years, with Alphabet writing off $1.1 billion of debt incurred from those losses in 2019, but it turned a modest profit of $60 million for the first time in 2020.

Deepmind/Bizzard Entertainment Related article Google's StarCraft-playing AI is crushing pro gamers Eventually, King envisions alerts about potential kidney problems coming straight to doctors and ...